Ryanodine receptors, voltage-gated calcium channels and their relationship with protein kinase A in the myocardium

Physiological Research

Volumn 57, Issue 2, 2008, Pages 141-149

  Petrovic M M ^a,b   Vales K ^b   Putnikovic B ^a   Djulejic V ^a   Mitrovic D M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Calcium channels; Heart failure; Protein kinase A; Ryanodine receptors

Indexed keywords

CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; RYANODINE RECEPTOR;

ANIMAL; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE TACHYCARDIA; HUMAN; METABOLISM; PHYSIOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HEART FAILURE; HUMANS; MYOCARDIUM; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SIGNAL TRANSDUCTION; TACHYCARDIA, VENTRICULAR;

EID: 45849140197     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (55)

1. ARMSTRONG CM, BEZANILLA FM, HOROWICZ P: Twitches in the presence of ethylene glycol bis(-aminoethyl ether)-N,N′-tetracetic acid. Biochim Biophys Acta 267: 605-608, 1972.
2. BERS DM, STIFFEL VM: Ratio of ryanodine to dihydropyridine receptors in cardiac and skeletal muscle and implications for E-C coupling. Am J Physiol 264: C1587-C1593, 1993.
3. BRISTOW M, GINSBURG R, MINOBE W, CUBICCIOTTI R, SAGEMAN W, LURIE K, BILLINGHAM M, HARRISON D, STINSON E: Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211, 1982.
4. 2+ channels. Annu Rev Cell Dev Biol 16: 521-555, 2000.
5. 2+ release channel (ryanodine receptor) expressed in HEK293 cells. J Biol Chem 272: 24234-24246, 1997.
6. CHUGH SS, SENASHOVA O, WATTS A, TRAN PT, ZHOU Z, GONG Q, TITUS JL, HAYFLICK SJ: Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol 43: 1625-1629, 2004.
7. DIRKSEN RT, BEAM KG Role of calcium permeation in dihydropyridine receptor function. Insights into channel gating and excitation-contraction coupling. J Gen Physiol 114: 393-403, 1999.
8. 2+ release. Biochem J 379: 161-172, 2004.
9. DULHUNTY AF, KARUNASEKARA Y, CURTIS SM, HARVEY PJ, BOARD PG, CASAROTTO MG: The recombinant dihydropyridine receptor II-III loop and partly structured 'C' region peptides modify cardiac ryanodine receptor activity. Biochem J 385: 803-813, 2005.
10. ERTEL EA, CAMPBELL KP, HARPOLD MM, HOFMANN F, MORI Y, PEREZ-REYES E, SCHWARTZ A, SNUTCH TP, TANABE T, BIRNBAUMER L: Nomenclature of voltage-gated calcium channels. Neuron 25: 533-535, 2000.
11. FILL M, COPELLO JA: Ryanodine receptor calcium release channels. Physiol Rev 82: 893-922, 2002.
12. FRANZINI-ARMSTRONG C: Functional implications of RyR-dHPR relationships in skeletal and cardiac muscles. Biol Res 37: 507-512, 2004.
13. FRANZINI-ARMSTRONG C, PROTASI F: Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol Rev 77: 699-729, 1997.
14. FRASER ID, TAVALIN SJ, LESTER LB, LANGEBERG LK, WESTPHAL AM, DEAN RA, MARRION NV, SCOTT JD: A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J 17: 2261-2272, 1998.
15. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19: 185-196, 1997.
16. GOTTLIEB SS, FISHER ML, KJEKSHUS J, DEEDWANIA P, GULLESTAD L, VITOVEC J, WIKSTRAND J: Tolerability of {beta}-blocker initiation and titration in the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Circulation 105: 1182-1188, 2002.
17. GRAY PC, TIBBS VC, CATTERALL WA, MURPHY BJ: Identification of a 15-kDa cAMP-dependent protein kinase-anchoring protein associated with skeletal muscle L-type calcium channels. J Biol Chem 272: 6297-6302, 1997.
18. GRUNWALD R, MEISSNER G: Lumenal sites and C terminus accessibility of the skeletal muscle calcium release channel (ryanodine receptor). J Biol Chem 270: 11338-11347, 1995.
19. HAKAMATA Y, NAKAI J, TAKESHIMA H, IMOTO K: Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett 312: 229-235, 1992.
20. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 91: 1015-1022, 2002.
21. 2+ channels in skeletal muscle cells requires anchored cAMP-dependent protein kinase. Proc Natl Acad SciUSA 91: 11492-11496, 1994.
22. KINUGAWA T, OGINO K, KITAMURA H, SAITOH M, OMODANI H, OSAKI S, HISATOME I, MIYAKODA H: Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am J Med Sci 312: 110-117, 1996.
23. KOHNO M, YANO M, KOBAYASHI S, DOI M, ODA T, TOKUHISA T, OKUDA S, OHKUSA T, KOHNO M, MATSUZAKI M: A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. Am J Physiol 284: H1035-H1042, 2003.
24. LEHNART SE, WEHRENS XHT, MARKS AR: Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biocheml Biophys Res Commun 322: 1267-1279, 2004.
25. LI Y, KRANIAS EG, MIGNERY GA, BERS DM: Protein kinase a phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 90: 309-316, 2002.
26. MARKS AR: A guide for the perplexed: towards an understanding of the molecular basis of heart failure. Circulation 107: 1456-1459, 2003.
27. MARKS AR, REIKEN S, MARX SO: Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation 105: 272-275, 2002.
28. 2+ release channels (ryanodine receptors). Science 281: 818-821, 1998.
29. MARX SO, GABURJÁKOVÁ J, GABURJÁKOVÁ M, HENRIKSON C, ONDRIÁŠ K, MARKS AR: Coupled gating between cardiac calcium release channels (ryanodine receptors). Circ Res 88: 1151-1158, 2001.
30. MARX SO, REIKEN S, HISAMATSU Y, JAYARAMAN T, BURKHOFF D, ROSEMBLIT N, MARKS AR: PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376, 2000.
31. MYERBURG RJ, CASTELLANOS A. Cardiovascular collapse, cardiac arrest and sudden cardiac death. In: Harrison's Principles of Internal Medicine. BRAUNWALD E, FAUCI AS, KASPER DL, HAUSER SL, LONGO DL, JAMESON LJ (eds), McGraw-Hill, New York, 2001, pp. 228-233.
32. NAKAI J, OGURA T, PROTASI F, FRANZINI-ARMSTRONG C, ALLEN PD, BEAM KG: Functional nonequality of the cardiac and skeletal ryanodine receptors. Proc Natl Acad Sci USA 94: 1019-1022, 1997.
33. POSTMA AV, DENJOY I, KAMBLOCK J, ALDERS M, LUPOGLAZOFF J-M, VAKSMANN G, DUBOSQ-BIDOT L, SEBILLON P, MANNENS MMAM, GUICHENEY P, WILDE AAM: Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 42: 863-870, 2005.
34. REIKEN S, WEHRENS XHT, VEST JA, BARBONE A, KLOTZ S, MANCINI D, BURKHOFF D, MARKS AR: {beta}-Blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107: 2459-2466, 2003.
35. 2+-release channels. Cell Calcium 32: 307-319, 2002.
36. SCULPTOREANU A, ROTMAN E, TAKAHASHI M, SCHEUER T, CATTERALL W: Voltage-dependent potentiation of the activity of cardiac L-type calcium channel α1 subunits due to phosphorylation by cAMP-dependent protein kinase. Proc Natl Acad Sci USA 90: 10135-10139, 1993.
37. 2+ release channel at 14 A resolution. J Mol Biol 345: 427-431, 2005.
38. 2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 93: 592-594, 2003.
39. 2+ release in cardiac myocytes. Acta Pharmacol Sin 27: 927-932, 2006.
40. SUN XH, PROTASI F, TAKAHASHI M, TAKESHIMA H, FERGUSON DG, FRANZINI-ARMSTRONG C: Molecular architecture of membranes involved in excitation-contraction coupling of cardiac muscle. J Cell Biol 129: 659-671, 1995.
41. SWAN H, PIIPPO K, VIITASALO M, HEIKKILA P, PAAVONEN T, KAINULAINEN K, KERE J, KETO P, KONTULA K, TOIVONEN L: Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 34: 2035-2042, 1999.
42. TESTER DJ, SPOON DB, VALDIVIA HH, MAKIELSKI JC, ACKERMAN MJ: Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc 79: 1380-1384, 2004.
43. TIMERMAN A, OGUNBUMNI E, FREUND E, WIEDERRECHT G, MARKS A, FLEISCHER S: The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem 268: 22992-22999, 1993.
44. TIMERMAN AP, ONOUE H, XIN H-B, BARG S, COPELLO J, WIEDERRECHT G, FLEISCHER S: Selective binding of FKBP12.6 by the cardiac ryanodine receptor. J Biol Chem 271: 20385-20391, 1996.
45. VERKHRATSKY A: Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 85: 201-279, 2005.
46. VEST JA, WEHRENS XH, REIKEN SR, LEHNART SE, DOBREV D, CHANDRA P, DANILO P, RAVENS U, ROSEN MR, MARKS AR: Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111: 2025-2032, 2005.
47. WEHRENS XH, LEHNART SE, REIKEN SR, DENG SX, VEST JA, CERVANTES D, COROMILAS J, LANDRY DW, MARKS AR: Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304: 292-296, 2004.
48. WEHRENS XH, LEHNART SE, REIKEN S, VAN DER NAGEL R, MORALES R, SUN J, CHENG Z, DENG SX, DE WINDT LJ, LANDRY DW, MARKS AR: Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci USA 102: 9607-9612, 2005.
49. WITCHER D, KOVACS R, SCHULMAN H, CEFALI D, JONES L: Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem 266: 11144-11152, 1991.
50. YANG J, DRAZBA JA, FERGUSON DG, BOND M: A-kinase anchoring protein 100 (AKAP100) is localized in multiple subcellular compartments in the adult rat heart. J Cell Biol 142: 511-522, 1998.
51. 2+ handling in heart failure. J Clin Invest 115: 556-564, 2005.
52. YOSHIDA A, TAKAHASHI M, IMAGAWA T, SHIGEKAWA M, TAKISAWA H, NAKAMURA T: Phosphorylation of ryanodine receptors in rat myocytes during β-adrenergic stimulation. J Biochem (Tokyo) 111: 186-190, 1992.
53. YUE DT, HERZIG S, MARBAN E: Beta-adrenergic stimulation of calcium channels occurs by potentiation of high-activity gating modes. Proc Natl Acad Sci USA 87: 753-757, 1990.
54. ZHANG L, KELLEY J, SCHMEISSER G, KOBAYASHI YM, JONES LR: Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 272: 23389-23397, 1997.
55. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 265: 2244-2256, 1990.